Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04144790 · ClinicalTrials.gov registry record
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
A clinical trial, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Completed
- Registry status
- 12
- Enrollment target
NCT04144790: Completed study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT04144790 is a clinical trial that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04144790 has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The goal of the present study is to provide novel data to evaluate brain iron concentration as a mediator of the association between iron supplementation treatment and improvement in symptoms of ADHD and RLS in children, including PLMS. Twelve participants between the ages of 10 and 15 years will be recruited via Kennedy Krieger Institute's Sleep Disorders Clinic. Eligible participants will be asked to complete, at baseline (pre-iron supplementation treatment) and again at follow-up (post-treatment): 1) a 7 Tesla MRI scan, 2) five consecutive nights of RestEaZe™ monitoring, 3) caregiver-reported (or patient-reported if over the age of 10 years) International Restless Leg Syndrome Scale (IRLSS), and 4) caregiver-reported ADHD Rating Scale-5. The treatment interval will be 3 months.
Primary Outcome
Change in ADHD symptoms measured by parent-reported ADHD-RS-V
Interventions
- DIETARY_SUPPLEMENT ferrous sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-09-15 |
| Est. Completion | 2025-06-30 |
What the finished NCT04144790 record still lists
NCT04144790 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ferrous sulfate is the first listed.
NCT04144790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04144790 about?
NCT04144790 is a clinical study titled "Impact of Iron Supplementation Treatment on Brain Iron Concentrations". The goal of the present study is to provide novel data to evaluate brain iron concentration as a mediator of the association between iron supplementation treatment and improvement in symptoms of ADHD and RLS in children, including PLMS. Twelve participants between the ages of 10 and 15 years will be...
What is the current status of trial NCT04144790?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2022-09-15. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT04144790?
The interventions under investigation include: ferrous sulfate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04144790?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI